These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 6106393)
21. Neuroleptic discontinuation and tardive dyskinesia risk. Sherr JD; Medoff D; Thaker G Am J Psychiatry; 1999 Jul; 156(7):1125-6. PubMed ID: 10401483 [No Abstract] [Full Text] [Related]
22. Tardive dyskinesia and other clinical consequences of neuroleptic treatment in children and adolescents. Gualtieri CT; Quade D; Hicks RE; Mayo JP; Schroeder SR Am J Psychiatry; 1984 Jan; 141(1):20-3. PubMed ID: 6140865 [TBL] [Abstract][Full Text] [Related]
23. Case study: worsening Tourette's disorder or withdrawal dystonia? Mennesson M; Klink BA; Fortin AH J Am Acad Child Adolesc Psychiatry; 1998 Jul; 37(7):785-8. PubMed ID: 9666635 [TBL] [Abstract][Full Text] [Related]
24. Transient Gilles de la Tourette syndrome following alcohol withdrawal. Sandyk R; Gillman MA Br J Addict; 1985 Jun; 80(2):213-4. PubMed ID: 3860244 [No Abstract] [Full Text] [Related]
25. Tardive Tourette's syndrome treated with clonidine and mesoridazine. Munetz MR; Slawsky RC; Neil JF Psychosomatics; 1985 Mar; 26(3):254, 257. PubMed ID: 2859628 [No Abstract] [Full Text] [Related]
30. [Risperidone use in child and adolescent psychiatric patients]. Chevreuil C; Reymann JM; Frémaux T; Polard E; Séveno T; Bentué-Ferrer D Therapie; 2008; 63(5):359-75. PubMed ID: 19154706 [TBL] [Abstract][Full Text] [Related]
31. Case report of neuroleptic malignant syndrome associated with withdrawal from amantadine. Simpson DM; Davis GC Am J Psychiatry; 1984 Jun; 141(6):796-7. PubMed ID: 6145359 [TBL] [Abstract][Full Text] [Related]
33. Neuroleptic malignant syndrome following levomepromazine discontinuation. Tanii H; Saka K; Inoue K; Okada M J Neuropsychiatry Clin Neurosci; 2010; 22(2):E16. PubMed ID: 20463130 [No Abstract] [Full Text] [Related]
34. Exacerbation of tics secondary to clozapine therapy. Bastiampillai T; Dhillon R; Mohindra R Aust N Z J Psychiatry; 2008 Dec; 42(12):1068-70. PubMed ID: 19034993 [No Abstract] [Full Text] [Related]
35. Opiate therapy and self-harming behavior in Tourette's syndrome. Bruun R; Kurlan R Mov Disord; 1991; 6(2):184-5. PubMed ID: 2057015 [No Abstract] [Full Text] [Related]
37. Neuroleptic malignant syndrome related to a switch to perospirone and anticholinergic withdrawal. Tanii H; Fujita K; Okazaki Y Am J Psychiatry; 2006 Mar; 163(3):547-8. PubMed ID: 16513884 [No Abstract] [Full Text] [Related]
38. Neuroleptic-related dyskinesias in autistic children: a prospective, longitudinal study. Campbell M; Armenteros JL; Malone RP; Adams PB; Eisenberg ZW; Overall JE J Am Acad Child Adolesc Psychiatry; 1997 Jun; 36(6):835-43. PubMed ID: 9183140 [TBL] [Abstract][Full Text] [Related]
39. The "psychotic" curse. Pary RJ Am J Psychiatry; 1979 May; 136(5):715-6. PubMed ID: 35015 [No Abstract] [Full Text] [Related]
40. Profanity: symptom or dyskinetic reaction? Skrabanek P Am J Psychiatry; 1980 Mar; 137(3):384-5. PubMed ID: 6101936 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]